Mini-broncho-alveolar lavage: A simple and promising method for assessment of antibiotic concentration in epithelial lining fluid

Intensive Care Medicine

Volumn 33, Issue 9, 2007, Pages 1495-1497

  Mimoz, Olivier ^a   Dahyot Fizelier, Claire ^a  

^a UNIVERSITÉ DE POITIERS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

TOBRAMYCIN;

ARTIFICIAL VENTILATION; BRONCHOSCOPY; CRITICALLY ILL PATIENT; DRUG INFUSION; EDITORIAL; HUMAN; LUNG ALVEOLUS EPITHELIUM; LUNG LAVAGE; VENTILATOR ASSOCIATED PNEUMONIA;

ANTI-BACTERIAL AGENTS; BRONCHOALVEOLAR LAVAGE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CRITICAL ILLNESS; HUMANS; INFUSIONS, INTRAVENOUS; INTENSIVE CARE UNITS; PNEUMONIA, VENTILATOR-ASSOCIATED; RESPIRATORY MUCOSA; TOBRAMYCIN;

EID: 34548176073     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00134-007-0689-9     Document Type: Editorial

References (21)

1. American Thoracic Society & Infectious Diseases Society of America (2005) Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 171:388-416
2. Craig WA (1998) Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clin Infect Dis 26:1-10
3. Joukhadar C, Frossard M, Mayer BX, Brunner M, Klein N, Siostrzonek P, Eichler HG, Müller M (2001) Impaired target site penetration of beta-lactams may account for therapeutic failure in patients with septic shock. Crit Care Med 29:385-391
4. Müller M, de la Pena A, Derendorf H (2004) Issues in pharmacokinetics and pharmacodynamics of anti-infective agents: distribution in tissue. Antimicrob Agents Chemother 48:1441-1453
5. Tomaselli F, Maier A, Matzi V, Smolle-Juttner FM, Dittrich P (2004) Penetration of meropenem into pneumonic human lung tissue as measured by in vivo microdialysis. Antimicrob Agents Chemother 48:2228-2232
6. Dahyot C, Marchand S, Pessini GL, Pariat C, Debaene B, Couet W, Mimoz O (2006) Microdialysis study of imipenem distribution in skeletal muscle and lung extracellular fluids of Acinetobacter baumannii-infected rats. Antimicrob Agents Chemother 50:2265-2267
7. Marchand S, Dahyot C, Lamarche I, Mimoz O, Couet W (2005) Microdialysis study of imipenem distribution in skeletal muscle and lung extracellular fluids of noninfected rats. Antimicrob Agents Chemother 49:2356-2361
8. Mimoz O, Rolland D, Adoun M, Marchand S, Breilh D, Brumpt I, Debaene B, Couet W (2006) Steady-state trough serum and epithelial lining fluid concentrations of teicoplanin 12 mg/kg per day in patients with ventilator-associated pneumonia. Intensive Care Med 32:775-779
9. Baldwin DR, Honeybourne D, Wise R (1992) Pulmonary disposition of antimicrobial agents: methodological considerations. Antimicrob Agents Chemother 36:1171-1175
10. Andrews JM, Honeybourne D, Jevons G, Brenwald NP, Cunningham D, Wise R (1997) Concentrations of levofloxacin (HR 355) in the respiratory tract following a single oral dose in patients undergoing fibre-optic bronchoscopy. J Antimicrob Chemother 40:573-577
11. Boselli E, Breilh D, Rimmele T, Djabarouti S, Toutain J, Chassard D, Saux MC, Allaouchiche B (2005) Pharmacokinetics and intrapulmonary concentrations of linezolid administered to critically ill patients with ventilator-associated pneumonia. Crit Care Med 33:1529-1533
12. Honeybourne D, Tobin C, Jevons G, Andrews J, Wise R (2003) Intrapulmonary penetration of linezolid. J Antimicrob Chemother 51:1431-1434
13. Conte JE Jr, Golden JA, Kipps J, Zurlinden E (2002) Intrapulmonary pharmacokinetics of linezolid. Antimicrob Agents Chemother 46:1475-1480
14. Boselli E, Breilh D, Rimmele T, Poupelin JC, Saux MC, Chassard D, Allaouchiche B (2004) Plasma and lung concentrations of ceftazidime administered in continuous infusion to critically ill patients with severe nosocomial pneumonia. Intensive Care Med 30:989-991
15. Boselli E, Breilh D, Cannesson M, Xuereb F, Rimmele T, Chassard D, Saux MC, Allaouchiche B (2004) Steady-state plasma and intrapulmonary concentrations of piperacillin/tazobactam 4 g/0.5 g administered to critically ill patients with severe nosocomial pneumonia. Intensive Care Med 30:976-979
16. Boselli E, Breilh D, Rimmele T, Djabarouti S, Saux MC, Chassard D, Allaouchiche B (2005) Pharmacokinetics and intrapulmonary diffusion of levofloxacin in critically ill patients with severe community-acquired pneumonia. Crit Care Med 33:104-109
17. Boselli E, Breilh D, Saux MC, Gordien JB, Allaouchiche B (2006) Pharmacokinetics and lung concentrations of ertapenem in patients with ventilator-associated pneumonia. Intensive Care Med 32:2059-2062
18. Boselli E, Breilh D, Duflo F, Saux MC, Debon R, Chassard D, Allaouchiche B (2003) Steady-state plasma and intrapulmonary concentrations of cefepime administered in continuous infusion in critically ill patients with severe nosocomial pneumonia. Crit Care Med 31:2102-2106
19. Boselli E (2007) Reliability of mini-bronchoalveolar lavage for the measurement of epithelial lining fluid concentrations of tobramycin in critically ill patients. Intensive Care Med (this issue) DOI 10.1007/s00134-007-0688-x
20. Carcas AJ, Garcia-Satue JL, Zapater P, Frias-Iniesta J (1999) Tobramycin penetration into epithelial lining fluid of patients with pneumonia. Clin Pharmacol Ther 65:245-250
21. Richer M, Allard S, Manseau L, Vallee F, Pak R, LeBel M (1995) Suction-induced blister fluid penetration of cefdinir in healthy volunteers following ascending oral doses. Antimicrob Agents Chemother 39:1082-1086